Literature DB >> 10023770

Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL.

J A Speir1, U M Abdel-Motal, M Jondal, I A Wilson.   

Abstract

T cell receptor (TCR) recognition of nonpeptidic and modified peptide antigens has been recently uncovered but is still poorly understood. Immunization with an H-2Kb-restricted glycopeptide RGY8-6H-Gal2 generates a population of cytotoxic T cells that express both alpha/beta TCR, specific for glycopeptide, and gamma/delta TCR, specific for the disaccharide, even on glycolipids. The crystal structure of Kb/RGY8-6H-Gal2 now demonstrates that the peptide and H-2Kb structures are unaffected by the peptide glycosylation, but the central region of the putative TCR binding site is dominated by the extensive exposure of the tethered carbohydrate. These features of the Kb/RGY8-6H-Gal2 structure are consistent with the individual ligand binding preferences identified for the alpha/beta and gamma/delta TCRs and thus explain the generation of a carbohydrate-specific T cell response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10023770     DOI: 10.1016/s1074-7613(00)80006-0

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  33 in total

Review 1.  Tissue distribution, antigen specificity and effector functions of gamma delta T cells in human diseases.

Authors:  G De Libero
Journal:  Springer Semin Immunopathol       Date:  2000

Review 2.  A new aspect in glycolipid biology: glycosphingolipids as antigens recognized by T lymphocytes.

Authors:  G De Libero; A Donda; H J Gober; V Manolova; Z Mazorra; A Shamshiev; L Mori
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

3.  A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor.

Authors:  Vasso Apostolopoulos; Elizabeth Yuriev; Paul A Ramsland; Jodie Halton; Carla Osinski; Wenjun Li; Magdalena Plebanski; Hans Paulsen; Ian F C McKenzie
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

4.  Processing of glycans on glycoprotein and glycopeptide antigens in antigen-presenting cells.

Authors:  Ole Werdelin; Morten Meldal; Teis Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

5.  O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma.

Authors:  D Stepensky; E Tzehoval; E Vadai; L Eisenbach
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

6.  An efficient and versatile mammalian viral vector system for major histocompatibility complex class I/peptide complexes.

Authors:  Ai Kawana-Tachikawa; Mariko Tomizawa; Jun-Ichi Nunoya; Tatsuo Shioda; Atsushi Kato; Emi E Nakayama; Tetsuya Nakamura; Yoshiyuki Nagai; Aikichi Iwamoto
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 7.  Lipopeptides: a novel antigen repertoire presented by major histocompatibility complex class I molecules.

Authors:  Daisuke Morita; Masahiko Sugita
Journal:  Immunology       Date:  2016-08-10       Impact factor: 7.397

Review 8.  High-affinity anti-glycan antibodies: challenges and strategies.

Authors:  Zinaida Polonskaya; Paul B Savage; M G Finn; Luc Teyton
Journal:  Curr Opin Immunol       Date:  2019-04-28       Impact factor: 7.486

Review 9.  Bridging innate and adaptive antitumor immunity targeting glycans.

Authors:  Anastas Pashov; Bejatolah Monzavi-Karbassi; Gajendra P S Raghava; Thomas Kieber-Emmons
Journal:  J Biomed Biotechnol       Date:  2010-06-15

10.  Critical role of glycosylation in determining the length and structure of T cell epitopes.

Authors:  Tamás G Szabó; Robin Palotai; Péter Antal; Itay Tokatly; László Tóthfalusi; Ole Lund; György Nagy; András Falus; Edit I Buzás
Journal:  Immunome Res       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.